Polypharmacy Is Now a Routine Safety Problem at the Bedside
Jonathan Bledsoe’s liver injury began with a symptom most patients would never link to medication harm: dark urine that looked like fresh brewed coffee. After he brought the change to his doctors, the interaction among his medicines came into focus, and once the regimen was changed, both liver and kidney function returned to normal. The episode is a blunt reminder that polypharmacy is not an abstract geriatric concern. It can become a real-time toxicology problem, especially when several prescribers and pharmacies are involved.
The number of older adults taking five or more medications has nearly doubled from 2000 to 2020, and more than a third of Americans over 65 now meet that definition. In practice, the count can be much higher. Amanda Mixon, a hospitalist and associate professor of bioinformatics at Vanderbilt University, said she sees older patients taking an average of 16 medications, often across multiple prescribers. Every added drug expands the chance of interactions, duplicate therapy, dose mismatch, and side effects that can be mistaken for a new disease.
A second problem compounds the first: many medication lists are fragmented. When physicians work in different health systems and pharmacies do not share the same view of a patient’s regimen, no single clinician may see the full picture. A sedating drug may be added for insomnia, a laxative for constipation, a bladder medication for urinary urgency, and a loop diuretic for fluid overload. Each prescription may make sense in isolation. Together, they can create dizziness, confusion, falls, dehydration, and organ injury.
Prescribing Cascades Can Turn One Side Effect Into Three More Drugs
The prescribing cascade is one of the clearest ways medication harm snowballs. A drug causes a symptom, the symptom is treated as a new condition, and the patient ends up with another prescription that may trigger yet another adverse effect. Mixon pointed to heart failure care as a common example: a water pill reduces fluid retention, but frequent urination can lead to incontinence, which then invites another medication. The biological logic is straightforward. Once a treatment shifts fluid balance, bowel function, sleep, blood pressure, cognition, or urinary control, the downstream effects can be misread as new disease rather than drug toxicity.
This is where bedside history-taking matters more than algorithmic prescribing. The patient who reports new constipation, diarrhea, memory loss, or unsteadiness may be describing a medication effect rather than a separate diagnosis. In older adults, physiologic reserve narrows, drug metabolism changes, and the same dose can produce a bigger response than it did years earlier. A regimen that was reasonable at 60 can become excessive at 80.
One sentence captures the risk plainly: more medicines can mean more harm.
Deprescribing Is Becoming Part of Medication Safety
“Deprescribing” refers to the intentional tapering or stopping of medications when the risks outweigh the benefits. The concept has gained momentum over the past decade as polypharmacy has become more common, but the practical skill set remains uneven. De-prescribing is not the same as refusing therapy or abandoning evidence-based care. It is a structured attempt to reduce avoidable harm, reassess indication, and ask whether each prescription still serves a current clinical goal.
DeLon Canterbury, a pharmacist and CEO of GeriatRx, said the aim is patient safety, not simply reducing the number of pills for its own sake. He described a medical culture that tends to add treatments for each symptom, often with good intentions. That pattern can be especially difficult to unwind because the evidence base for tapering safely is newer, and the process is not widely taught in medical schools. Stopping one medicine may require close follow-up, dose reduction, or substitution rather than abrupt withdrawal.
The patient-facing message is practical: if a new symptom appears after a medication is started, or if a long list of drugs no longer seems coherent, the conversation should not wait for the next crisis. Canterbury urged patients to raise the question directly with a specialist or primary care clinician. The point is not to challenge expertise. It is to make sure the clinician revisits the original reason for each drug and checks whether the risk profile has changed.
A Medication List Can Prevent Duplicate Treatment and Missed Interactions
The simplest safety tool may be the most effective: an updated medication list. Jen Hammons, director of rural health advancement at the Appalachian College of Pharmacy in Virginia, said everyone needs one in a pocket if they cannot hold the full regimen in memory. That list should include prescription drugs, over-the-counter products, vitamins, and supplements. Even seemingly harmless additions can alter bleeding risk, blood pressure, sedation, or liver metabolism.
Paper still has value here. QR-code bracelets and medication apps can help, but they fail if the phone is dead, the app is outdated, or the patient cannot access the device in an emergency. A paper list handed to each clinician can expose duplicate prescriptions, reveal a recent dose change, and shorten the time to identifying an interaction. For people seeing several specialists, the list can serve as a single source of truth when the health record is split across systems.
The stakes rise when side effects are subtle. Falls, constipation, diarrhea, and memory loss may not trigger alarm immediately, yet these are exactly the kinds of problems that can trace back to medication burden. In older adults, those symptoms can spiral into hospitalization, functional decline, or loss of independence. A list does not solve every problem, but it gives patients a concrete way to participate in safety monitoring.
Coverage Policy Is Catching Up Slowly
Federal policy is beginning to acknowledge that deprescribing takes time. This year, the Centers for Medicare & Medicaid Services released guidance clarifying how physicians and pharmacists can be paid for medication review and tapering when appropriate. The change matters because medication reduction is not a quick administrative task. It requires reconciliation, counseling, follow-up, and careful documentation of why a drug should continue, be reduced, or be stopped.
The policy shift also lands in a politically charged environment. Health and Human Services Secretary Robert F. Kennedy Jr. has called for reducing psychiatric medication use, a position that has divided clinicians. Whatever the politics, the clinical need is broader than any single drug class. Older adults taking multiple medications face avoidable risks across cardiology, psychiatry, gastroenterology, and primary care. The challenge is to distinguish necessary treatment from medication inertia.
A final problem remains unresolved at the bedside: the same pill that once improved quality of life may later become part of the problem. The only safe way to know is to review the full list, ask what has changed, and be willing to taper when the balance no longer favors treatment.